MedTrace Logo

Tissue Collection for Studies of Lymph Cancer

NCT01676805 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1295

Last updated 2026-05-05

No results posted yet for this study

Summary

Background:

\- Lab studies help researchers better understand cancer biology. This information may lead to new methods for diagnosing or treating cancer. To develop these studies, researchers want to collect samples from people with cancer or precancer conditions of the lymph system. These conditions include multiple myeloma, different types of lymphoma, and adult leukemia/lymphoma. The samples collected will include blood, urine, bone marrow, and tumor and skin tissue.

Objectives:

\- To collect tissue samples to study different types of lymph cancer.

Eligibility:

\- Individuals at least 18 years of age who have a lymphoid cancer or precancer condition.

Design:

* Participants will be screened with a physical exam and medical history.
* Different samples will be collected for study. Blood samples will be collected at the initial testing. More blood samples will be collected at different treatment points. Other liquid samples include urine, bone marrow, and any abnormal fluid. Tumor tissue and skin tissue biopsies will also be collected for study.
* Treatment will not be provided as part of this study.

Conditions

  • Hodgkin Disease
  • Lymphoma, Non-Hodgkin
  • Multiple Myeloma
  • Lymphomatoid Granulomatosis
  • Leukemia-Lymphoma, Adult T-Cell

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Christopher J Melani, M.D. · National Cancer Institute (NCI)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-21

Countries

  • United States
  • Jamaica

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01676805 on ClinicalTrials.gov